Notice of Results

RNS Number : 3025R

Circassia Pharmaceuticals Plc

07 March 2016

 

7 March 2016

Circassia Pharmaceuticals PLC

Notice of Preliminary Results

Circassia Pharmaceuticals plc (LSE: CIR), a specialty biopharmaceutical company focused on allergy and respiratory medicine, will announce its preliminary results for the year ended 31 December 2015 on Friday 11 March 2016. 

A presentation for analysts will take place at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD at 9.30am. A webcast of the presentation will be available on the Company's website.

For further information please contact:

FTI Consulting
Mo Noonan / Matt Moss	[phone]

 

END

 

 

NORZMGGFKNGGVZM